@natera.comFour of our abstracts were selected for oral presentations at the #ASTRO26 Annual Meeting, showcasing the expanding clinical utility of Signatera™ across tumor types and treatment settings.
Learn more about our latest data: https://ow.ly/PK9250ZWwa5
#ASTRO26
@alliance-org.bsky.socialLate-breaking news from #ASTRO26: Alliance for Clinical Trials in Oncology Phase III trial (A071801) finds 3-5 sessions of radiosurgery after surgery for large brain metastases outperforms single-session treatment in reducing local recurrence and boosting survival. https://bit.ly/ASTRO26
@renalurologynews.bsky.socialMore from #ASTRO26! The PAM50 luminal B tumor status may be a biomarker to select ADT candidates among patients requiring salvage radiation for post-surgical detectable or rising PSA.
Read more about this study here: https://bit.ly/4jQ3owO
@dximaging-mjh.bsky.socialWhat New Dosimetry Data Reveals About 177Lu-Edotreotide for GEP-NET Treatment
www.diagnosticimaging.com/view/new-dos...
#radiology #RadRes #ASTRO26
@aapmhq.bsky.socialICYMI: October Monthly Minute is live 🎙️ President Robin Miller joins from #ASTRO26 with updates on AAPM's leadership transition/Executive Director search, dues renewal & the website refresh.
@renalurologynews.bsky.socialThe @fda.gov has granted 510(k) clearance for SpaceOAR™ Flex Hydrogel by @bostonsci.bsky.social
It’s the latest iteration in #RectalSpacer technologies from the company.
For more information, plus details from the study presented at #ASTRO26, click the link below🔽
https://bit.ly/4j8OOAl
@alliance-org.bsky.social📰 Media highlights featuring Alliance research: 🧠 ASTRO '26: Multi-fraction SRS reduces brain met recurrence 🩸 ALL: Pediatric regimen effective in adults 40+ 🩺 Breast Cancer: FDA approval backed by AFT-38/PATINA
Full roundup: https://bit.ly/Sept-Media #ASTRO26 #clinicaltrials
@healthcare-europe.bsky.socialUsing implanted collagen tiles during #brain #surgery, a new kind of #radiationtherapy (TBRT) could significantly lower the risk of recurrence in brain #metastases, a new study led by 🇺🇸 @mdanderson.bsky.social, presented at #ASTRO26, finds. #TBRT
@artera.aiThat’s a wrap on #ASTRO26!
Thank you to everyone who connected with the Artera team throughout the meeting. We enjoyed the conversations and the opportunity to spend time with the radiation oncology community.
Until next year! 👋
@medpagetoday.comHypofractionated postmastectomy radiotherapy continued to provide locoregional control for patients with high-risk breast cancer, 10-year data from a phase III trial showed. @astro-org.bsky.social #ASTRO26
https://www.medpagetoday.com/meetingcoverage/astro/123247
@radiology-ai.bsky.socialBenchmarking of AI and Radiologists for Indeterminate Lung Nodule Malignancy Risk Estimation on Screening CT: The LUNA25 Challenge buff.ly/7oIngrf @ASTRO_org #ASTRO26 #RadOnc #OncoRad #radiology
@radiology-ai.bsky.socialImage Quality in the Era of Artificial Intelligence: Understanding the Limitations of AI-based Image Reconstruction and Postprocessing https://doi.org/10.1148/ryai.260100 #ASTRO26 #RadOnc #OncoRad #radiology
@radiology-ai.bsky.socialChecklist for Artificial Intelligence in Medical Imaging (CLAIM): Explanation, Elaboration, and Examples https://doi.org/10.1148/ryai.260835 #ASTRO26 #RadOnc #OncoRad #radiology
@radiology-ai.bsky.socialDMUVL-DiagNet: a new model for accurate characterization of superficial LA using dual-modality US videos https://doi.org/10.1148/ryai.260131 #ASTRO26 #RadOnc #OncoRad #radiology
@fumikochino.bsky.socialWe clean up nice.
Dining, dancing, and fundraising for cutting edge #radonc research all while honoring the amazing #ASTRO26 Gold Medal Honorees. 🏅💃🕺☢️⚡️ Speed of Light: The @astro-org.bsky.social Foundation #GoldMedalGala
@nrgonc.bsky.socialWe're recapping all of the great NRG research presented at #ASTRO26 - Check it out: https://conta.cc/4d23LAn
#InternationalPodcastDay🎙️
@radiology-ai.bsky.socialPredetermined Change Control Plan Adoption and Documentation Transparency in U.S. Food and Drug Administration–cleared Radiology Artificial Intelligence/Machine Learning Devices https://doi.org/10.1148/ryai.260385 #ASTRO26 #RadOnc #OncoRad #radiology
@yalecancer.bsky.socialBeatrice Katsnelson shared analysis of 2,186 patients with #NSCLC, noting KEAP1 & SMARCA4 tumor mutations predicted development of bone mets. Findings suggest molecular profiling could identify high-risk pts and increase surveillance strategies. #ASTRO26
@astro-org.bsky.social @oncoalert.bsky.social
@yalecancer.bsky.socialDr. Victor Lee shared that patients with #prostatecancer & TP53 mutations had higher pathologic lymph node involvement. Noting incorporating TP53 mutational status into risk stratification models could improve patient selection for elective nodal irradiation. #ASTRO26 @oncoalert.bsky.social
@yalecancer.bsky.socialDr. Mary-Kate Lawlor presented new data #ASTRO26 showing in 81 patients with stage III uterine serous carcinoma, #EBRT significantly improved pelvic control + OS vs vaginal brachytherapy alone (4-year OS 87% vs. 55%) without increased toxicity.
@astro-org.bsky.social @oncoalert.bsky.social
